Moderna Q4 net income down 70% to $1.5B; FY2022 revenue $19.3B; reiterates $5B COVID sales for 2023

Moderna, Inc.

2022-FY EPS reported $20.12 revenue$19,263,000,000

Q4 2022 revenue $5.1B (down 29% YoY from $7.2B); GAAP diluted EPS $3.61 (down 68% from $11.29).
Full-year 2022 revenue $19.3B (up 4% from $18.5B); GAAP net income $8.4B (down 31% from $12.2B); diluted EPS $20.12.
Cost of sales surged to 39% of product sales in Q4 (from 14% YoY) due to $297M inventory write-downs, $281M purchase commitment losses, $376M unutilized capacity charges.
R&D spending increased 87% to $1.2B in Q4; full-year R&D $3.3B (up 65%); 2023 R&D guidance $4.5B.
Juan Andres, President of Strategic Partnerships, to retire in May 2023; Jerh Collins joined as CTOO in October 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Moderna, Inc. reported the fiscal year ended December 31, 2022 results: revenue $19.3 billion, net income $8.4 billion, EPS $20.12. Guidance reaffirmed.

Period: the fiscal year ended December 31, 2022
Revenue: $19.3 billion
Net income: $8.4 billion
EPS: $20.12
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Full-year 2022 revenues of $19.3 billion; GAAP net income of $8.4 billion and GAAP diluted EPS of $20.12

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Moderna, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $5.1 billion, net income $1.5 billion, EPS $3.61. Guidance reaffirmed.

Period: the fourth quarter ended December 31, 2022
Revenue: $5.1 billion
Net income: $1.5 billion
EPS: $3.61
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Updates Fourth quarter 2022 revenues of $5.1 billion; GAAP net income of $1.5 billion and GAAP diluted EPS of $3.61

View on SEC.gov

Browse all earnings releases →

Moderna, Inc. filing history →

Source: SEC EDGAR

accession 0001682852-23-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.